Clinical Trial: Safety and Efficacy of NRT6008 Administered in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Carcinoma (LAPC)

U.S., April 30 -- ClinicalTrials.gov registry received information related to the study (NCT07555587) titled 'Safety and Efficacy of NRT6008 Administered in Combination With Chemotherapy in Patients With Unresectable Locally Advanced Pancreatic Carcinoma (LAPC)' on April 16.

Brief Summary: This is a phase Ib, open-label study to evaluate safety and efficacy of NRT6008 in combination with standard-of-care chemotherapy in patients with unresectable Locally Advanced Pancreatic Carcinoma (LAPC).

Study Start Date: Sept., 2026

Study Type: INTERVENTIONAL

Condition: Unresectable Locally Advanced Pancreatic Carcinoma

Intervention: DEVICE: NRT6008 Injection

In this study, all participants shall receive NRT6008 injection (for 200 Gy tumour tis...